22/07/2021

Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites

20/07/2021

EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

03/07/2021

EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
29/06/2021

A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property

We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
29/06/2021

EV Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes

EuropaBio is pleased to announce that EV Biotech has joined the organization as an Associate Member.
23/06/2021

Interview with… Dr. Jernej Pintar, CEO and Head of Tech Community at Technology Park Ljubljana

EuropaBio sat down with new Member Technology Park Ljubljana, to find out about their journey from creation in 1994.
23/06/2021

Technology Park Ljubljana joins EuropaBio: better world through better technology

EuropaBio is pleased to announce that Technology Park Ljubljana has joined the organization as part of the National Associations Council.
16/06/2021

EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines

14/06/2021

European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation

14/06/2021

Novartis is proud to support the EuropaBio 25th Anniversary

EuropaBio is delighted to announce that Novartis has joined EuropaBio’s 25th Anniversary Celebration Programme as a Sponsor.
09/06/2021

Interview with Cyrille Pauthenier, CEO of Abolis Biotechnologies – The Bio-Synthesis Architects

EuropaBio sat down with new Member Lallemand, to find out what fires them up for the future of industrial biotechnology.
07/06/2021

EuropaBio invited healthcare biotech SMEs to learn about EU Policy Priorities

07/06/2021

Pragmatic IP solutions and strong collaborations will ensure faster global access to vaccines

31/05/2021

EuropaBio Key Messages to 94th Pharmaceutical Committee – 28 May 2021

27/05/2021

EuropaBio welcomes the EU strategy on Covid-19 therapeutics

27/05/2021

EuropaBio meets EMA to exchange views on topics of common interest

2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 1 & 2 2021_05_H_O_EMA-EuropaBio bilateral meeting_Agenda items 4 & 5
25/05/2021

Alliance for Regenerative Medicine, European Federation of Pharmaceutical Industries and Associations, and European Association for Bioindustries Call for Advanced Therapies to be Exempt from EU GMO Legislation

EuropaBio welcomes the in-depth opinion of the European Group on Ethics on the uses of genome editing and thanks the Group for raising the awareness of a technology which will enable the development of many solutions for healthy people and planet.
20/05/2021

EuropaBio Patient BioForum: Advancing Patient Access to Innovative Treatments

20/05/2021

Decentralised clinical trials, the future of clinical research

The COVID-19 pandemic has been a catalyst for change which has led us to revisit the way we conduct clinical trials.
20/05/2021

Advanced Therapies bring tranformational value to European patients

Become a member